A novel mechanism of H2 against cervical cancer is revealed, which may serve as a potential therapeutic target in clinical practice and RNA sequencing and GO analysis suggest that downregulated HIF1A (HIF-1α mRNA) and RelA (NF-κB p65) levels, and reduced NF-κBs signaling were associated with the antitumor effect of H 2.
